Adaptive Biotechnologies (ADPT) Leases (2020 - 2025)
Historic Leases for Adaptive Biotechnologies (ADPT) over the last 6 years, with Q3 2025 value amounting to $42.0 million.
- Adaptive Biotechnologies' Leases fell 976.14% to $42.0 million in Q3 2025 from the same period last year, while for Sep 2025 it was $42.0 million, marking a year-over-year decrease of 976.14%. This contributed to the annual value of $45.8 million for FY2024, which is 1214.87% down from last year.
- As of Q3 2025, Adaptive Biotechnologies' Leases stood at $42.0 million, which was down 976.14% from $43.3 million recorded in Q2 2025.
- Adaptive Biotechnologies' 5-year Leases high stood at $92.1 million for Q2 2021, and its period low was $42.0 million during Q3 2025.
- Its 5-year average for Leases is $68.2 million, with a median of $77.1 million in 2023.
- As far as peak fluctuations go, Adaptive Biotechnologies' Leases soared by 18496.36% in 2021, and later plummeted by 3817.68% in 2024.
- Over the past 5 years, Adaptive Biotechnologies' Leases (Quarter) stood at $87.7 million in 2021, then decreased by 7.89% to $80.8 million in 2022, then plummeted by 35.5% to $52.1 million in 2023, then fell by 12.15% to $45.8 million in 2024, then dropped by 8.26% to $42.0 million in 2025.
- Its Leases stands at $42.0 million for Q3 2025, versus $43.3 million for Q2 2025 and $44.0 million for Q1 2025.